LEXICON PHARMACEUTICALS, INC. (LXRX) Operating income 2016–2025
LEXICON PHARMACEUTICALS, INC. (LXRX) annual operating income history from SEC filings — each fiscal year as reported.
-$48.9MFY2025 · since FY2016: -$127.2M → -$48.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$48.9M | +75.2% |
| FY2024 | -$197.1M | -14.8% |
| FY2023 | -$171.8M | -70.5% |
| FY2022 | -$100.8M | -15.7% |
| FY2021 | -$87.1M | -82.2% |
| FY2020 | -$47.8M | -133.8% |
| FY2019 | $141.4M | +237.0% |
| FY2018 | -$103.3M | +20.9% |
| FY2017 | -$130.6M | -2.7% |
| FY2016 | -$127.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LXRX financial trends
LXRX RevenueLXRX Net incomeLXRX Net marginLXRX Gross profitLXRX Gross marginLXRX Operating marginLXRX Operating cash flowLXRX Free cash flowLXRX Capital expendituresLXRX Return on equityLXRX Stock buybacksLXRX Dividends paidLXRX Total assetsLXRX Total liabilitiesLXRX Shareholders’ equityLXRX overview →